{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:02:35Z","timestamp":1777536155534,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T00:00:00Z","timestamp":1352505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10157-012-0722-3","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T03:03:08Z","timestamp":1352430188000},"page":"396-404","source":"Crossref","is-referenced-by-count":9,"title":["N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial"],"prefix":"10.1007","volume":"17","author":[{"given":"Ricardo M.","family":"Heguil\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amador A.","family":"Liste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Payaslian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Gabriel","family":"Ortemberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lautaro Martin","family":"Albarrac\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia Rita","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,10]]},"reference":[{"key":"722_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/pcad.2003.YPCAD16","volume":"45","author":"C Briguori","year":"2003","unstructured":"Briguori C, Tavano D, Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis. 2003;45:493\u2013503.","journal-title":"Prog Cardiovasc Dis"},{"key":"722_CR2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","volume":"103","author":"PA McCullough","year":"1997","unstructured":"McCullough PA, Wolyn R, Rocher LL, Levin RN, O\u2032Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368\u201375.","journal-title":"Am J Med"},{"issue":"3","key":"722_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/clc.20576","volume":"33","author":"D Castini","year":"2010","unstructured":"Castini D, Lucreziotti S, Bosotti L, et al. Prevention of contrast-induced nephropathy: a single center randomized study. Clin Cardiol. 2010;33(3):63\u20138.","journal-title":"Clin Cardiol"},{"issue":"4","key":"722_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/bja\/aem237","volume":"99","author":"GTC Wong","year":"2007","unstructured":"Wong GTC, Irwin MG. Contrast-induced nephropathy. Br J Anaesth. 2007;99(4):474\u201383.","journal-title":"Br J Anaesth"},{"issue":"11","key":"722_CR5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1503\/cmaj.1040847","volume":"172","author":"I Goldenberg","year":"2005","unstructured":"Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005;172(11):1461\u201371.","journal-title":"CMAJ"},{"key":"722_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198901193200303","volume":"320","author":"PS Parfrey","year":"1989","unstructured":"Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"722_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","volume":"348","author":"P Aspelin","year":"2003","unstructured":"Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491\u20139.","journal-title":"N Engl J Med"},{"key":"722_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2214\/AJR.07.3370","volume":"191","author":"MJ Kuhn","year":"2008","unstructured":"Kuhn MJ, Chen N, Sahani DV, et al. The PREDICT Study: a randomized double-blind comparison of contrast-induced nephropathy after low or isoosmolar contrast agent exposure. AJR. 2008;191:151\u20137.","journal-title":"AJR"},{"key":"722_CR9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa023204","volume":"349","author":"G Marenzi","year":"2003","unstructured":"Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333\u201340.","journal-title":"N Engl J Med"},{"key":"722_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/heart.85.4.361","volume":"85","author":"CSR Baker","year":"2001","unstructured":"Baker CSR, Baker LRI. Prevention of contrast nephropathy after cardiac catheterization. Heart. 2001;85:361\u20132.","journal-title":"Heart"},{"issue":"21","key":"722_CR11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","volume":"331","author":"R Solomon","year":"1994","unstructured":"Solomon R, Werner C, Mann D, D\u2019Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331(21):1416\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"722_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","volume":"47","author":"MR Rudnick","year":"1995","unstructured":"Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int. 1995;47(1):254\u201361.","journal-title":"Kidney Int"},{"issue":"17","key":"722_CR13","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.290.17.2284","volume":"290","author":"GE Stone","year":"2003","unstructured":"Stone GE, McCullough PA, W for the CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290(17):2284\u201391.","journal-title":"JAMA"},{"key":"722_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-1755.1999.00528.x","volume":"56","author":"GL Bakris","year":"1999","unstructured":"Bakris GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int. 1999;56:206\u201310.","journal-title":"Kidney Int"},{"issue":"2","key":"722_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.1985.32","volume":"27","author":"G Bakris","year":"1985","unstructured":"Bakris G, Burnett J. A role for calcium in radiocontrast induced reductions in renal hemodynamics. Kidney Int. 1985;27(2):465\u20138.","journal-title":"Kidney Int"},{"issue":"11","key":"722_CR16","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/ndt\/17.11.1936","volume":"17","author":"A Kapoor","year":"2002","unstructured":"Kapoor A, Kumar S, Gulati S, Gambhir S, Sethi R, Sinha N. The role of theophylline in contrast-induced nephropathy: a case\u2013control study. Nephrol Dial Transpl. 2002;17(11):1936\u201341.","journal-title":"Nephrol Dial Transpl"},{"key":"722_CR17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.2233010609","volume":"223","author":"W Huber","year":"2002","unstructured":"Huber W, Ilgmann K, Page M, et al. Effect of theophylline on contrast material\u2013induced nephropathy in patients with chronic renal insufficiency: controlled randomized, double-blinded study. Radiology. 2002;223:772\u20139.","journal-title":"Radiology"},{"key":"722_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM200007203430311","volume":"343","author":"R Safirstein","year":"2000","unstructured":"Safirstein R, Andrade L, Vieira JM. N-acetylcysteine and nephrotoxic effects of RC agents: a new use for an old drug. N Engl J Med. 2000;343:210\u20132.","journal-title":"N Engl J Med"},{"issue":"2","key":"722_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000185304","volume":"51","author":"JL Teruel","year":"1989","unstructured":"Teruel JL, Maracen R, Herrero JA, Ortuno FJ. An easy and effective procedure to prevent radiocontrast nephrotoxicity in high-risk patients [letter]. Nephron. 1989;51(2):282.","journal-title":"Nephron"},{"key":"722_CR20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-148-4-200802190-00007","volume":"148","author":"AM Kelly","year":"2008","unstructured":"Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Int Med. 2008;148:284\u201394.","journal-title":"Ann Int Med"},{"key":"722_CR21","first-page":"153","volume":"2","author":"SN Heyman","year":"1994","unstructured":"Heyman SN, Rosen S, Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol. 1994;2:153\u20137.","journal-title":"Exp Nephrol"},{"key":"722_CR22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ki.1991.255","volume":"40","author":"SN Heyman","year":"1991","unstructured":"Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int. 1991;40:632\u201342.","journal-title":"Kidney Int"},{"key":"722_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI113612","volume":"82","author":"SN Heyman","year":"1988","unstructured":"Heyman SN, Brezis M, Reubinoff CA, et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest. 1988;82:401\u201312.","journal-title":"J Clin Invest"},{"issue":"10","key":"722_CR24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","volume":"332","author":"M Brezis","year":"1995","unstructured":"Brezis M, Rosen S. Hypoxia of the renal medulla\u2014its implications for disease. N Engl J Med. 1995;332(10):647\u201355.","journal-title":"N Engl J Med"},{"issue":"1","key":"722_CR25","first-page":"15","volume":"17","author":"MR Rudnick","year":"1997","unstructured":"Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Semin Nephrol. 1997;17(1):15\u201326.","journal-title":"Semin Nephrol"},{"key":"722_CR26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4065\/75.12.1275","volume":"75","author":"A Pflueger","year":"2000","unstructured":"Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. 2000;75:1275\u201383.","journal-title":"Mayo Clin Proc"},{"key":"722_CR27","doi-asserted-by":"crossref","first-page":"F115","DOI":"10.1152\/ajpcell.1990.258.1.C115","volume":"258","author":"GL Bakris","year":"1990","unstructured":"Bakris GL, Lass N, Gaber AO, Jones J, Burnett J Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258:F115\u201320.","journal-title":"Am J Physiol"},{"key":"722_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1148\/radiology.175.1.2315505","volume":"175","author":"GL Bakris","year":"1990","unstructured":"Bakris GL, Gabaer AO, Jones JD. Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. Radiology. 1990;175:57\u201360.","journal-title":"Radiology"},{"issue":"1","key":"722_CR29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","volume":"32","author":"R Katholi","year":"1998","unstructured":"Katholi R, Woods T Jr, Taylor G, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32(1):64\u201371.","journal-title":"Am J Kidney Dis"},{"key":"722_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000259899","volume":"31","author":"HC Lee","year":"2010","unstructured":"Lee HC, Sheu SH, Yen HW, Lai WT, Chang JG. JNK\/ATF2 pathway is involved in iodinated contrast media-induced apoptosis. Am J Nephrol. 2010;31:125\u201333.","journal-title":"Am J Nephrol"},{"issue":"3","key":"722_CR31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"M Tepel","year":"2000","unstructured":"Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by N-acetylcysteine. N Engl J Med. 2000;343(3):180\u20134.","journal-title":"N Engl J Med"},{"key":"722_CR32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0735-1097(02)02308-2","volume":"40","author":"KG Skyu","year":"2002","unstructured":"Skyu KG, Cheng JJ, Kuan P. N-acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002;40:1383\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"722_CR33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.289.5.553","volume":"289","author":"J Kay","year":"2003","unstructured":"Kay J, Chow WH, Chan TM, et al. N-acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. 2003;289(5):553\u20138.","journal-title":"JAMA"},{"issue":"12","key":"722_CR34","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","volume":"41","author":"CS Baker","year":"2003","unstructured":"Baker CS, Wragg A, Kuman S, De Palma R, Baker L, Knight C. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol. 2003;41(12):2114\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"722_CR35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(03)14189-X","volume":"362","author":"R Birck","year":"2003","unstructured":"Birck R, Krzossk S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet. 2003;362:598\u2013603.","journal-title":"Lancet"},{"issue":"18","key":"722_CR36","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.0000146396.19081.73","volume":"110","author":"K Spargias","year":"2004","unstructured":"Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004;110(18):2837\u201342.","journal-title":"Circulation"},{"key":"722_CR37","first-page":"455","volume-title":"The kidney","author":"RJ Alpern","year":"2000","unstructured":"Alpern RJ. Renal acidification mechanisms. In: Brenner BM, editor. The kidney. 6th ed. Philadelphia, PA: WB Saunders; 2000. p. 455\u2013519.","edition":"6"},{"key":"722_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0076-6879(90)86093-B","volume":"186","author":"B Halliwell","year":"1990","unstructured":"Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 1990;186:1\u201385.","journal-title":"Methods Enzymol"},{"key":"722_CR39","first-page":"55","volume-title":"CRC handbook of methods for oxygen radical research","author":"G Cohen","year":"1985","unstructured":"Cohen G. The Fenton reaction. In: Greenwald RA, editor. CRC handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press Inc; 1985. p. 55\u201364."},{"issue":"19","key":"722_CR40","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","volume":"291","author":"GJ Merten","year":"2004","unstructured":"Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA. 2004;291(19):2328\u201334.","journal-title":"JAMA"},{"key":"722_CR41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/hrt.2004.039636","volume":"91","author":"VO Gomes","year":"2005","unstructured":"Gomes VO, Poli de Figueredo CE, Caramori P, et al. N-acethylcysteine does not prevent contrast induced nephropathy after cardiac catheterization with an ionic low osmolality contrast medium: a multicenter clinical trial. Heart. 2005;91:774\u20138.","journal-title":"Heart"},{"key":"722_CR42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","volume":"39","author":"K Nash","year":"2002","unstructured":"Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930\u20136.","journal-title":"Am J Kidney Dis"},{"key":"722_CR43","doi-asserted-by":"crossref","unstructured":"McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Med. 2006; 98 Suppl 6A:5K\u201313K.","DOI":"10.1016\/j.amjcard.2006.01.019"},{"issue":"7","key":"722_CR44","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"722_CR45","doi-asserted-by":"crossref","unstructured":"Goldenberg I, Shechter M, Matetzky S, et al. Oral acethylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. Eur Heart J. 2004;25:212\u20138.","DOI":"10.1016\/j.ehj.2003.11.011"},{"key":"722_CR46","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2008.05.026","volume":"52","author":"M Maioli","year":"2008","unstructured":"Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol. 2008;52:599\u2013604.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"722_CR47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2008.08.033","volume":"53","author":"SD Navaneethan","year":"2009","unstructured":"Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgai AR. Sodium bicarbonate therapy for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(4):617\u201327.","journal-title":"Am J Kidney Dis"},{"key":"722_CR48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1525-1497.2005.30323.x","volume":"20","author":"R Liu","year":"2005","unstructured":"Liu R, Nair D, Ix J, Moore DH, Bent S. N-acethylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med. 2005;20:193\u2013200.","journal-title":"J Gen Intern Med"},{"key":"722_CR49","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","volume":"354","author":"G Marenzi","year":"2006","unstructured":"Marenzi G, Assanelli E, Marana I. N-acethylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773\u201382.","journal-title":"N Engl J Med"},{"issue":"11","key":"722_CR50","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrneph.2010.116","volume":"6","author":"AD Calvin","year":"2010","unstructured":"Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol. 2010;6(11):679\u201388.","journal-title":"Nat Rev Nephrol"},{"key":"722_CR51","doi-asserted-by":"crossref","unstructured":"ACT Investigators. Acethylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography. Main results from the randomized acethylcysteine for contrast-induced nephropathy trial (ACT). Circulation. 2011;124:1250\u20139.","DOI":"10.1161\/CIRCULATIONAHA.111.038943"},{"key":"722_CR52","doi-asserted-by":"crossref","unstructured":"Kunadian V, Zaman A, Spyridopoulos I, Qiu W. Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur J Radiol. 2010; doi: 10.1016\/j.ejrad.2009.12.015 .","DOI":"10.1016\/j.ejrad.2009.12.015"},{"key":"722_CR53","first-page":"345A","volume":"14","author":"M Novikov","year":"2003","unstructured":"Novikov M, Molitoris B, Campos S, et al. Renoprotective properties of acetazolamide in a rat model of contrast media induced renal failure (abstract). J Am Soc Nephrol. 2003;14:345A.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"722_CR54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ndt\/gfp389","volume":"25","author":"EA Hoste","year":"2010","unstructured":"Hoste EA, De Waele JJ, Gevaert SA, Uchino S, Kellum JA. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transpl. 2010;25(3):747\u201358.","journal-title":"Nephrol Dial Transpl"},{"key":"722_CR55","doi-asserted-by":"crossref","unstructured":"Zoungas S, Nimomiya T, Huxley R, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Int Med. 2009;11(9):631\u20138.","DOI":"10.7326\/0003-4819-151-9-200911030-00008"},{"issue":"1","key":"722_CR56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2215\/CJN.03100707","volume":"3","author":"AM From","year":"2008","unstructured":"From AM, Bartholmai BJ, Williams AW, Cha SS, Pfluger A, McDonald FS. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy. A retrospective cohort study of 7977 patients at Mayo Clinic. Clin J Am Soc Nephrol. 2008;3(1):10\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"722_CR57","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.freeradbiomed.2003.08.019","volume":"35","author":"DE Richardson","year":"2003","unstructured":"Richardson DE, Regino CA, Yao H, Johnson JV. Methionineoxidation by hydrogen peroxymonocarbonate, a reactive oxygen species formed from CO2\/bicarbonate and hydrogen peroxide. Free Radic Biol Med. 2003;35(12):1538\u201350.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"722_CR58","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","volume":"14","author":"J Mishra","year":"2003","unstructured":"Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14(10):2534\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"722_CR59","doi-asserted-by":"crossref","unstructured":"Haase M, Bellomo R, Decarajan P, Schlattmann P, Haase-Fielitz A, the NGAL Meta-Analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1012\u201324.","DOI":"10.1053\/j.ajkd.2009.07.020"},{"key":"722_CR60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000227785","volume":"28","author":"S Soni","year":"2009","unstructured":"Soni S, Ronco C, Katz N, Cruz D. Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purify. 2009;28:165\u201374.","journal-title":"Blood Purify"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-012-0722-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0722-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T12:04:23Z","timestamp":1562328263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-012-0722-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,10]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1007\/s10157-012-0722-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,10]]}}}